nach oben

Diabetologia

Erschienen in:

01.03.2011 | Article

Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes

verfasst von: M. M. H. Al-Gayyar, S. Matragoon, B. A. Pillai, T. K. Ali, M. A. Abdelsaid, A. B. El-Remessy

Erschienen in: Diabetologia | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Accumulation of pro-nerve growth factor (NGF), the pro form of NGF, has been detected in neurodegenerative diseases. However, the role of proNGF in the diabetic retina and the molecular mechanisms by which proNGF causes retinal neurodegeneration remain unknown. The aim of this study was to elucidate the role of proNGF in neuroglial activation and to examine the neuroprotective effects of epicatechin, a selective inhibitor of tyrosine nitration, in an experimental rat model of diabetes.

Methods

Expression of proNGF and its receptors was examined in retinas from streptozotocin-induced diabetic rats, and in retinal Müller and retinal ganglion cells (RGCs). RGC death was assessed by TUNEL and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays in diabetic retinas and cell culture. Nitrotyrosine was determined using Slot-blot. Activation of the tyrosine kinase A (TrkA) receptor and p38 mitogen-activated protein kinase (p38MAPK) was assessed by western blot.

Results

Diabetes-induced peroxynitrite impaired phosphorylation of TrkA-Y490 via tyrosine nitration, activated glial cells and increased expression of proNGF and its receptor, p75 neurotrophin receptor (p75^NTR), in vivo and in Müller cells. These effects were associated with activation of p38MAPK, cleaved poly-(ADP-ribose) polymerase and RGC death. Treatment of diabetic animals with epicatechin (100 mg kg⁻¹ day⁻¹, orally) blocked these effects and restored neuronal survival. Co-cultures of RGCs with conditioned medium of activated Müller cells significantly reduced RGC viability (44%). Silencing expression of p75^NTR by use of small interfering RNA protected against high glucose- and proNGF-induced apoptosis in RGC cultures.

Conclusions/interpretation

Diabetes-induced peroxynitrite stimulates p75^NTR and proNGF expression in Müller cells. It also impairs TrkA receptor phosphorylation and activates the p75^NTR apoptotic pathway in RGCs, leading to neuronal cell death. These effects were blocked by epicatechin, a safe dietary supplement, suggesting its potential therapeutic use in diabetic patients.

Nur mit Berechtigung zugänglich

American Diabetes Association (2007) Diabetes Statistics. Available from www.diabetes.org/diabetes-basics/diabetes-statistics/?utm_source=WWW&utm_medium=DropDownDB&utm_content=Statistics&utm_campaign=CON, accessed November 2010

Ali TK, El-Remessy AB (2009) Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy 29:182–192CrossRefPubMed

Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Investig 102:783–791CrossRefPubMed

Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Investig Ophthalmol Vis Sci 46:2210–2218CrossRef

Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Investig Ophthalmol Vis Sci 45:3330–3336CrossRef

El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI (2006) Neuroprotective and blood–retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168:235–244CrossRefPubMed

Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting NGF survival signal in experimental and human diabetes. J Diab 57:889–898CrossRef

Azar ST, Major SC, Safieh-Garabedian B (1999) Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus. Brain Behav Immun 13:361–366CrossRefPubMed

Park KS, Kim SS, Kim JC et al (2008) Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am J Ophthalmol 145:432–437CrossRefPubMed

10.

Ali TK, Al-Gayyar MMH, Matragoon S et al. (2010) Diabetes-induced peroxynitrite impairs the balance of ProNGF/NGF and causes neurovascular injury. Diabetologia doi:10.1007/s00125-010-1935-1

11.

Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science New York, NY 294:1945–1948

12.

Hempstead BL (2009) Commentary: Regulating proNGF action: multiple targets for therapeutic intervention. Neurotox Res 16:255–260CrossRefPubMed

13.

Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716–719CrossRefPubMed

14.

von Bartheld CS (1998) Neurotrophins in the developing and regenerating visual system. Histol Histopathol 13:437–459

15.

Fahnestock M, Yu G, Michalski B et al (2004) The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J Neurochem 89:581–592CrossRefPubMed

16.

Masoudi R, Ioannou MS, Coughlin MD et al (2009) Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem 284:18424–18433CrossRefPubMed

17.

El-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB (2005) Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:243–252CrossRefPubMed

18.

El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162:1995–2004CrossRefPubMed

19.

El-Remessy AB, Khalifa Y, Ola S, Liou G (2010) Diabetes-induced tyrosine nitration impairs glutamine synthetase activity: protective effects of cannabidiol. Mol Vis 16:1487–1495PubMed

20.

El-Remessy AB, Khalil IE, Matragoon S et al (2003) Neuroprotective effect of (−)Δ⁹-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163:1997–2008CrossRefPubMed

21.

Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy AB (2010) Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther 332:125–134CrossRefPubMed

22.

Al-Gayyar MMH, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2010) Neuro and vascular protective effect of FeTPPs in NMDA-model: similarities to diabetes. Am J Pathol 177:1187–1197CrossRefPubMed

23.

Krishnamoorthy RR, Agarwal P, Prasanna G et al (2001) Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 86:1–12CrossRefPubMed

24.

Sarthy VP, Brodjian SJ, Dutt K, Kennedy BN, French RP, Crabb JW (1998) Establishment and characterization of a retinal Muller cell line. Investig Ophthalmol Vis Sci 39:212–216

25.

Lebrun-Julien F, Bertrand MJ, De Backer O et al (2010) ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Natl Acad Sci USA 107:3817–3822CrossRefPubMed

26.

El-Remessy AB, Al-Shabrawey M, Platt DH et al (2007) Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J 21:2528–2539CrossRefPubMed

27.

Carmignoto G, Comelli MC, Candeo P et al (1991) Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol 111:302–311CrossRefPubMed

28.

Suzuki A, Nomura S, Morii E, Fukuda Y, Kosaka J (1998) Localization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells. J Neurosci Res 54:27–37CrossRefPubMed

29.

Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L (2008) Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefe's Archive for Clinical and Experimental Ophthalmology=Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 246:1743–1749PubMed

30.

Ferruzzi MG, Lobo JK, Janle EM et al (2009) Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J Alzheimers Dis 18:113–124PubMed

31.

Roghani M, Baluchnejadmojarad T (2009) Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vasc Pharmacol 51:84–89CrossRef

32.

Yamabe N, Yokozawa T, Oya T, Kim M (2006) Therapeutic potential of (−)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 319:228–236CrossRefPubMed

33.

Schroeder P, Klotz LO, Buchczyk DP, Sadik CD, Schewe T, Sies H (2001) Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem Biophys Res Commun 285:782–787CrossRefPubMed

34.

Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771–779CrossRefPubMed

35.

Harada T, Harada C, Nakayama N et al (2000) Modification of glial–neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 26:533–541CrossRefPubMed

36.

Srinivasan B, Roque CH, Hempstead BL, Al-Ubaidi MR, Roque RS (2004) Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 279:41839–41845CrossRefPubMed

37.

Madsen-Bouterse S, Mohammad G, Kowluru RA (2010) Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy. Investig Ophthalmol Vis Sci 51:1765–1772CrossRef

38.

Zou MH, Shi C, Cohen RA (2002) High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51:198–203CrossRefPubMed

39.

Zhan X, Du Y, Crabb JS, Gu X, Kern TS, Crabb JW (2008) Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics 7:864–874CrossRefPubMed

40.

Lee KF, Li E, Huber LJ et al (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69:737–749CrossRefPubMed

41.

Pehar M, Cassina P, Vargas MR et al (2004) Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 89:464–473CrossRefPubMed

42.

Vargas MR, Pehar M, Cassina P, Estevez AG, Beckman JS, Barbeito L (2004) Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo 18:269–274PubMed

43.

Loeb DM, Maragos J, Martin-Zanca D, Chao MV, Parada LF, Greene LA (1991) The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 66:961–966CrossRefPubMed

44.

Rankin SL, Guy CS, Mearow KM (2005) TrkA NGF receptor plays a role in the modulation of p75NTR expression. Neurosci Lett 383:305–310CrossRefPubMed

45.

Rankin SL, Guy CS, Rahimtula M, Mearow KM (2008) Neurotrophin-induced upregulation of p75NTR via a protein kinase C-delta-dependent mechanism. Brain Res 1217:10–24CrossRefPubMed

46.

Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C (2004) Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 47:1055–1063CrossRefPubMed

47.

Wiese S, Metzger F, Holtmann B, Sendtner M (1999) The role of p75NTR in modulating neurotrophin survival effects in developing motoneurons. Eur J Neurosci 11:1668–1676CrossRefPubMed

48.

Kust BM, Brouwer N, Mantingh IJ, Boddeke HW, Copray JC (2003) Reduced p75NTR expression delays disease onset only in female mice of a transgenic model of familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 4:100–105CrossRef

49.

Turner BJ, Cheah IK, Macfarlane KJ et al (2003) Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J Neurochem 87:752–763CrossRefPubMed

50.

Kitzman PH, Perrone TN, LeMaster AM, Davis BM, Albers KM (1998) Level of p75 receptor expression in sensory ganglia is modulated by NGF level in the target tissue. J Neurobiol 35:258–270CrossRefPubMed

Titel: Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes
verfasst von: M. M. H. Al-Gayyar
S. Matragoon
B. A. Pillai
T. K. Ali
M. A. Abdelsaid
A. B. El-Remessy
Publikationsdatum: 01.03.2011
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 3/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1994-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2011

Intensified glucose lowering in type 2 diabetes: don’t throw the baby out with the bathwater

TNF-α acutely upregulates amylin expression in murine pancreatic beta cells

Erratum: Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes

Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study

Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer. Reply to Yang XL, Ma RCW, Chan JCN [letter]